View in EDS

Chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target.

Saved in:
Bibliographic Details
Title: Chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target.
Authors: Bambal V; Dayananda Sagar University, Harohalli, Bengaluru, India., Kodihalli Basavaraj P; Dayananda Sagar University, Harohalli, Bengaluru, India., Vanaja K; Dayananda Sagar University, Harohalli, Bengaluru, India. vanajak-sps@dsu.edu.in.
Source: Inflammopharmacology [Inflammopharmacology] 2025 Aug; Vol. 33 (8), pp. 4477-4498. Date of Electronic Publication: 2025 Aug 08.
Publication Type: Journal Article; Review
Journal Info: Publisher: Birkhäuser Country of Publication: Switzerland NLM ID: 9112626 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1568-5608 (Electronic) Linking ISSN: 09254692 NLM ISO Abbreviation: Inflammopharmacology Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40779011
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bambal+V%22">Bambal V</searchLink>; Dayananda Sagar University, Harohalli, Bengaluru, India.<br /><searchLink fieldCode="AU" term="%22Kodihalli+Basavaraj+P%22">Kodihalli Basavaraj P</searchLink>; Dayananda Sagar University, Harohalli, Bengaluru, India.<br /><searchLink fieldCode="AU" term="%22Vanaja+K%22">Vanaja K</searchLink>; Dayananda Sagar University, Harohalli, Bengaluru, India. vanajak-sps@dsu.edu.in.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229112626%22">Inflammopharmacology</searchLink> [Inflammopharmacology] 2025 Aug; Vol. 33 (8), pp. 4477-4498. <i>Date of Electronic Publication: </i>2025 Aug 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Birkhäuser%22">Birkhäuser </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9112626 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1568-5608 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209254692%22">09254692 </searchLink><i>NLM ISO Abbreviation: </i>Inflammopharmacology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40779011
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10787-025-01871-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4477
    Titles:
      – TitleFull: Chemokine receptor type-5: a key regulator of immunity, disease pathogenesis, and emerging therapeutic target.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bambal V
      – PersonEntity:
          Name:
            NameFull: Kodihalli Basavaraj P
      – PersonEntity:
          Name:
            NameFull: Vanaja K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2025 Aug
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1568-5608
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: Inflammopharmacology
              Type: main
ResultId 1